This brief describes progress in the Child Welfare and Health Infrastructure for Linking and Data Analysis of Resources, Effectiveness, and Needs (CHILDREN) Initiative, which is in its fourth year. At this time, four jurisdictions participate in the CHILDREN Initiative: District of Columbia, Iowa, Oklahoma, and Wyoming.
Data
ASPE uses and produces data as key components of its work. ASPE studies and assesses data and how it is captured, managed, analyzed and protected, including the interplay of the sources, systems, standards for data that support policy, practice and research.
ASPE also co-chairs the HHS Data Council, which is the principal internal advisory body to the Secretary on health and human services data policy. The Council coordinates data policy activities in HHS, including the development and implementation of an HHS data strategy, and conducts research to improve long-term collection and use of HHS data.
ASPE’s work involves many types of data produced by HHS and other governmental programs and other partners. For example:
- Through its Foundations for Evidence-Based Policies Act of 2018 (“Evidence Act”) and Data Council responsibilities, ASPE leads HHS efforts to improve the quality and accessibility of its data assets.
- Through its investments under the aegis of the Office of the Secretary Patient-Centered Outcomes Research Trust Fund (OS-PCORTF), ASPE supports interoperability through such products as linked datasets involving mortality data, HL7 implementation guides in support of FHIR for research use of electronic health records, claims and other data, and natural language processing approaches.
- Through the use of ASPE-developed supplemental data tables, ASPE has developed issue brief series examining options before and after the passage of the American Rescue Plan Act of 2021 (ARP).
- Through its issue briefs such as this brief on Medicare Telehealth utilization trends, ASPE provides unique and timely data and analyses on important policy issues.
- Pursuant to the Social Security Act, ASPE annually calculates and publishes the Federal Medical Assistance Percentage (FMAP), enhanced Federal Medicaid Assistance Percentage (e-FMAP), and disaster-recovery FMAP for all states, the District of Columbia, and territories. The FMAP is used to determine federal funding for Medicaid/CHIP, Temporary Assistance for Needy Families (TANF) Contingency Funds, and other public programs. The FY 2022 FMAP notice was published in the Federal Register on November 30, 2020.
Noteworthy
Reports
Displaying 1 - 10 of 692. 10 per page. Page 1.
Advanced SearchASPE Issue Brief
Project Update: Child Welfare and Health Infrastructure for Linking and Data Analysis of Resources, Effectiveness, and Needs Initiative
ASPE Issue Brief
Financing Medicaid Through Provider Taxes on Hospitals: Spillover Effects on Employment-Based Coverage Premiums
KEY POINTSThe average state provider tax law, which typically taxed a hospital up to 3.5 percent of net patient revenue, resulted in an increase in ESI premiums of 1.5-1.7 percent, plus any spillover effect on interstate markets for provider resources.
ASPE Data Point
Health and Economic Benefits Associated with Increased Kidney Transplantation Following the Advancing American Kidney Health Initiative in 2019
KEY POINTSAnnual growth in the number of kidney transplants began to accelerate in 2019.
Research Brief
Children in Child Welfare are More Likely to be Prescribed Psychotropic Medication than Other Children on Medicaid: Findings from Florida and Kentucky
The use of psychotropic medications in children is a complex issue for parents, caregivers, health care professionals, researchers, and policymakers. Psychotropic medications are used to treat behavioral health conditions. When these medications are prescribed appropriately, they can be effective in managing behavioral health symptoms.
Report
Evidence-Based Measures for Chronic Disease Outcomes: A Review of Available Measures for Emergent HIV Therapies
The team conducted an environmental scan to explore the patient-reported outcome measures (PROMs) that could be used in new and emerging human immunodeficiency virus (HIV) therapies. In the context of HIV clinical trials, PROMs may be used as clinical outcome assessments (COAs) to characterize how patients feel and function and to inform regulatory evaluations.
Report
Evidence-Based Measures for Chronic Disease Outcomes: A Review of Available Measures for Emergent Sickle Cell Disease Therapies
The team conducted an environmental scan to explore the patient-reported outcome measures (PROMs) that could be used in new and emerging sickle cell disease (SCD) therapies.
Report
Market Forces in Medicare Reimbursement: Traditional Medicare, Medicare Advantage, and Provider Resource Constraints
EXECUTIVE SUMMARYMedicare reimbursement is administered, but it is not insulated from markets for provider labor, capital, facilities, and technology. Traditional Medicare payment formulas incorporate market-basket input prices, geographic wage indexes, case mix, and quality adjustments; total spending also depends on utilization.
ASPE Issue Brief, Report
Aligning Initiatives to End the HIV Epidemic in the United States
KEY POINTSThe Ryan White HIV/AIDS Program (RWHAP) provides critical services to low-income peo
Research Brief
Title IV-E Foster Care Eligibility Rates Have Declined While Determination Costs Have Increased: Meanwhile Eligibility Review Results Have Varied Since FY00
This brief synthesizes national caseload and expenditure data related to Title IV-E foster care eligibility and summarizes the Children’s Bureau’s published Title IV-E foster care eligibility review findings. Key findings include:
Report
An Overview of State-Directed Payments and Medicaid Provider Taxes: History and Potential Effects of the Working Families Tax Cut Legislation on Health Care Costs
Health care provider taxes and state-directed payment policies in the Working Families and Tax Cut legislation are expected to reduce non-Medicaid prices by up to 3.5 percent in markets with provider taxes and reduce spending on Medicaid, commercial and Medicare coverage.